Also, inhibition of IL-6-JAK/STAT3 signalling result in the enhancement of NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels, in castration-resistant prostate cancer cells (82). This evidence concerns the gene STAT3 and prostate carcinoma.